Differential awakening of the sciatic nerve: illustrative case Authors: William D. Chow, Pavlos Texakalidis, Felipe J. S. Jones, Robert J. Spinner Published: 2026 ABSTRACT BACKGROUNDDifferential awakening is a well-known, yet poorly understood phenomenon seen in patients with intracranial pathologies. Because acute postoperative neurological decline has many potentially reversible causes, distinguishing differential awakening from other etiologies is critical. To the authors’ knowledge, differential awakening has not been reported following peripheral nerve procedures.OBSERVATIONSA 40-year-old man presented with a 1.5-year history of painful bilateral cervical and right lumbosacral radiculoplexus neuropathy recently associated with bilateral facial and vestibulocochlear neuropathy. He had not responded to treatment trials. A sciatic nerve lesion in the sciatic notch was identified on imaging and an open biopsy of the posterior femoral cutaneous nerve was pursued. Immediately after emergence from anesthesia, he demonstrated a complete inability to dorsiflex or plantar flex the right foot, despite minimal intraoperative manipulation of the sciatic nerve. Over the ensuing hour, motor function progressively returned to baseline. The transient postoperative motor deficit was attributed to differential awakening of the sciatic nerve. Pathological analysis confirmed high-grade B-cell lymphoma.LESSONSDifferential awakening may be an underrecognized cause of transient neurological worsening during emergence from anesthesia following peripheral nerve surgery. Further investigation is needed to clarify the underlying mechanisms and define its incidence and risk factors. https://thejns.org/doi/10.3171/CASE251028 Differential awakening is a postoperative phenomenon in which patients with structural or vascular brain lesions exhibit a transient worsening and/or delayed return of neurological function on awakening from anesthesia.1 First described by anesthesiologist Roy Cucchiara in 1992, its underlying mechanism remains incompletely understood.1 Proposed explanations include altered anesthetic uptake, distribution, and/or metabolism in diseased regions of the brain; heightened sensitivity of neurons within or adjacent to abnormal tissue; and reduced neuronal redundancy in areas of injury, rendering deficits more apparent after anesthetic exposure.2 Importantly, differential awakening can complicate immediate postoperative neurological assessment. When new deficits occur after surgery, other etiologies, including hemorrhage, ischemia, cerebral edema, and iatrogenic injury, must be urgently considered in addition to differential awakening. Although differential awakening is well described in patients with intracranial lesions, to our knowledge it has not been reported in the peripheral nervous system. We present the case of a patient diagnosed with neurolymphomatosis (manifesting with painful bilateral cervical and right lumbosacral radiculoplexus neuropathy and bilateral facial and vestibulocochlear neuropathy); his return to baseline function immediately after emerging from anesthesia from the biopsy was delayed, which was attributed to differential awakening. Illustrative Case A 40-year-old man first presented to our institution in November 2025. Symptoms began in April 2024 with numbness of the left foot, progressing to involve the right foot by July 2024. Over the subsequent month, he developed acute right ankle plantar flexion and dorsiflexion weakness, followed by proximal right gluteal weakness that impaired stair climbing. He underwent evaluation in September 2024 at an outside institution, including EMG (without demyelinating features), lumbar puncture (mildly elevated protein only), muscle biopsy, and MRI of his lumbar spine (reportedly normal). He was diagnosed with multifocal chronic inflammatory demyelinating polyneuropathy and started on prednisone, with substantial improvement in right foot weakness and subsequent worsening during steroid taper. In November 2024, he developed acute left arm weakness accompanied by burning, sharp pain in the left shoulder and upper arm. He was treated with intravenous immunoglobulin without improvement. In February 2025, his left arm and right leg weakness worsened, and repeat EMG demonstrated findings concerning for proximal demyelination. He began a 6-week course of methylprednisolone with improvement in strength after each dose and partial regression prior to the next. In April 2025, mycophenolate was initiated as a steroid-sparing agent; however, he experienced worsening right quadriceps weakness the following month and received rituximab (loading dose). Within several weeks, he noted improvement in left arm and right leg strength. In August 2025, he developed acute right facial weakness that progressed to complete right hemifacial paralysis, followed shortly thereafter by acute left facial weakness progressing to complete paralysis within 1 week. Around this time, he also developed left-sided tinnitus, oscillopsia, and gait imbalance. Brain MRI demonstrated nonspecific enhancement in the facial nerves and auditory canals bilaterally. In September 2025, he underwent five sessions of plasma exchange without clinical improvement. His symptoms continued to worsen, including severe retroauricular pain bilaterally and pain in the left arm and right leg. He presented to the emergency department five times for uncontrolled pain requiring intravenous opioids. In November 2025, he developed new acute right distal upper extremity weakness and was started on efgartigimod alfa. Shortly after initiation, he presented to our institution for further evaluation. He reported a recent 10-pound weight loss, leg pain with urination, and profuse diaphoresis. Neurological examination demonstrated severe bilateral lower motor neuron facial palsies, bilateral vestibulocochlear dysfunction with profound hearing loss, asymmetric multifocal weakness involving the bilateral upper extremity and right lower extremity with associated muscle atrophy, and diffusely reduced reflexes. Gait was wide-based and antalgic with right-sided steppage. Given the combination of painful multifocal neuropathy, severe cranial neuropathies, systemic symptoms, and refractoriness to immunotherapy, neurolymphomatosis was considered high on the differential diagnosis. Further workup was planned, including repeat EMG, PET, MRI, lumbar puncture, and hematological/serological studies. Within the following week, he re-presented to the emergency department with markedly worsened right lower extremity and right shoulder pain. Brain MRI demonstrated interval progression of the previously visualized lesions in the bilateral facial nerves and internal auditory canals. MRI of the lumbar spine demonstrated thickened, T2-enhancing ventral nerve roots involving the conus medullaris and the L3 and S1 levels (Fig. 1), and an elongated homogeneous enhancing intradural mass was seen extending through the right neural foramen of L3–4 and right S1 root. All of these lesions were intensely PET avid. Additional foci of FDG uptake were also noted in the right L3 neuroforamen, spinal cord at T11–L1, spinal cord at C5–6, and bilateral C7 nerve roots. Small foci were also noted in the bilateral trigeminal nerves and anterior to the bilateral thalami. Comprehensive CSF studies were notable for rare atypical cells suspicious for lymphoma, along with elevated protein; however, it was felt that the results remained insufficient for diagnosis. A subcuteanous fat aspirate was performed and was negative for amyloid. After consultation with the neurology team, biopsy was requested for diagnostic clarification. FIG. 1.A and B:Axial T2-weighted (A) and T1-weighted contrasted (B) MR images showing a hyperintense, enhancing lesion involving the right sciatic nerve near the sciatic notch. C: PET image showing the lesion’s increased avidity. A and B:Axial T2-weighted (A) and T1-weighted contrasted (B) MR images showing a hyperintense, enhancing lesion involving the right sciatic nerve near the sciatic notch. C: PET image showing the lesion’s increased avidity. Based on the imaging abnormalities, a decision was made to biopsy the lesion in the right sciatic notch. A percutaneous image-guided biopsy was considered. Given his relatively good overall function in the right foot (grade 3–4/5 peroneal and tibial innervated muscles), the previous unsuccessful attempts at establishing a diagnosis, and the known challenges in diagnosing and characterizing neurolymphoma (which was the suspected diagnosis), we felt it was safer and of higher yield to perform a limited open biopsy targeting a branch (posterior cutaneous nerve of the thigh or a hamstring branch) and/or the tibial division of the sciatic nerve.3 The procedure proceeded uneventfully under propofol and fentanyl anesthesia. With the patient prone, a 7-cm skin incision was made in the upper one-third of the buttock. A transgluteal approach was undertaken. The posterior femoral cutaneous nerve was identified superficially and appeared markedly enlarged (Fig. 2A). While the sciatic nerve was identified deep in the wound, it was not dissected. Intraoperative stimulation (with a disposable nerve stimulator) of the cutaneous nerve did not produce any muscle contraction; stimulation of the sciatic nerve elicited robust muscle contractions in the tibial and peroneal distributions. As the posterior cutaneous nerve appeared pathological and representative of lesional tissue, a decision was made to biopsy it by itself. A 7-cm segment of the posterior femoral cutaneous nerve was resected (Fig. 2B). Frozen-section analysis was suggestive of lymphoma. A final intraoperative stimulation was performed, which again elicited robust muscle contractions in the tibial and peroneal distributions. FIG. 2.A:Through a transgluteal approach, the sciatic nerve was identified deep in the wound. The posterior cutaneous nerve was seen more superficially and was traced from distal to proximal into the lesion. B: Targeted biopsy of the posterior cutaneous nerve was done. A:Through a transgluteal approach, the sciatic nerve was identified deep in the wound. The posterior cutaneous nerve was seen more superficially and was traced from distal to proximal into the lesion. B: Targeted biopsy of the posterior cutaneous nerve was done. Immediately on emergence from anesthesia, in the recovery room, the patient demonstrated complete loss of dorsiflexion and plantar flexion on the biopsied side. The dressing was removed and no hematoma was observed. Given that the deficit was complete (not evolving) at the onset, the wound was quite dry at closure, and there was no evidence of swelling or hematoma, a decision was made to observe the patient. While emergency imaging was considered, in view of the findings at surgery and the appearance of the incision site postoperatively, we planned to perform imaging studies in several hours if there were no clinical recovery. After 30 minutes, dorsiflexion improved to 3/5 but plantar flexion was only a flicker. By 1 hour, strength returned to the patient’s preoperative baseline, strongly suggestive against an evolving, compressive hematoma. At outpatient follow-up, motor function had fully returned to baseline, with residual posterior thigh numbness consistent with posterior femoral cutaneous nerve biopsy. Final pathological analysis confirmed high-grade B-cell lymphoma with MYC and BCL6 rearrangements (Fig. 3). The patient was admitted 11 days later to his outside home institution and was promptly initiated on HyperCVAD (high-dose methotrexate + cytarabine), with plans to continue outpatient rituximab. FIG. 3.Representative sections from a posterior cutaneous nerve of the thigh biopsy demonstrate extensive lymphomatous infiltration. A: Hematoxylin and eosin stain showing confluent sheets of atypical lymphoid cells infiltrating the epineurium and extending into the perineurium and endoneurium. There is marked heterogeneity between fascicles, with one fascicle largely preserving normal architecture and an adjacent fascicle showing near-complete replacement by atypical cells. B:Masson’s trichrome stain highlighting multifocal loss of myelinated nerve fibers and disruption of normal fascicular architecture. C: CD45 immunohistochemical analysis demonstrating a dense lymphocytic infiltrate. D: CD68 immunohistochemical analysis highlighting scattered macrophages within the infiltrate. E: CD3 immunohistochemical analysis showing a minor population of T lymphocytes. F: CD20 immunohistochemical analysis revealing that the infiltrate is predominantly composed of B cells, consistent with B-cell lymphoma infiltrating the nerve (neurolymphomatosis). Representative sections from a posterior cutaneous nerve of the thigh biopsy demonstrate extensive lymphomatous infiltration. A: Hematoxylin and eosin stain showing confluent sheets of atypical lymphoid cells infiltrating the epineurium and extending into the perineurium and endoneurium. There is marked heterogeneity between fascicles, with one fascicle largely preserving normal architecture and an adjacent fascicle showing near-complete replacement by atypical cells. B:Masson’s trichrome stain highlighting multifocal loss of myelinated nerve fibers and disruption of normal fascicular architecture. C: CD45 immunohistochemical analysis demonstrating a dense lymphocytic infiltrate. D: CD68 immunohistochemical analysis highlighting scattered macrophages within the infiltrate. E: CD3 immunohistochemical analysis showing a minor population of T lymphocytes. F: CD20 immunohistochemical analysis revealing that the infiltrate is predominantly composed of B cells, consistent with B-cell lymphoma infiltrating the nerve (neurolymphomatosis). Informed Consent The necessary informed consent was obtained in this study. Discussion Observations To our knowledge, this is the first report describing differential awakening involving a peripheral nerve. Transient worsening of neurological symptoms after anesthesia in patients with CNS injury has been described in case reports and small case series since the early 1980s.4–6 Mechanistic studies to date have focused on CNS pathology, and proposed contributors include disturbances in cerebral perfusion and structural injury to the brain parenchyma.2 Thal et al. reported that fentanyl and midazolam could each independently induce focal motor deterioration in adults with carotid disease or brain tumors; notably, 73% of patients with baseline focal motor deficits demonstrated exacerbation after exposure.2 Furthermore, the ability of the two anesthetics to independently induce differential awakening suggested that the phenomenon could occur irrespective of the exact mechanism of action of the anesthetic.2 In a 2016 randomized, single-blind study, Lin et al. found that patients with frontotemporoparietal brain tumors were more susceptible to augmentation or unmasking of neurological dysfunction following sedation with midazolam or propofol.7 More recently, Plitman et al. reported that postoperative neurological deficits occurred more frequently after awake craniotomy for tumor resection among patients who received benzodiazepine sedation.8 Notably, our patient received propofol and fentanyl for both induction and maintenance of anesthesia. Interestingly, we found no prior reports describing differential awakening in the setting of primary CNS lymphoma. However, it is plausible that primary CNS lymphoma—an infiltrative process associated with blood-brain barrier disruption, abnormal vasculature, and altered metabolic dynamics9—could render surrounding brain parenchyma susceptible to anesthesia-related, transient neurological worsening similar to that described in gliomas or cerebral ischemia. We suspect a comparable mechanism in our patient with neurolymphomatosis involving the lumbosacral plexus/sciatic nerve and, more recently, the cranial nerves. In particular, disruption of the blood-nerve barrier may create regional differences in anesthetic delivery and/or clearance, in addition to low healthy axonal reserve due to tumor infiltration, and local tissue injury with edema may contribute to temporary motor deficits. We furthermore wonder if parallels may be drawn to phenomena such as stroke recrudesence and multiple sclerosis pseudoflares, where previously resolved or compensated deficits may reemerge in the setting of systemic stressors. Two case reports describing differential awakening in the setting of spinal pathology have been published. Miller et al. reported the case of a 74-year-old woman with cervical spine disease who underwent a C3–4 laminectomy under diazepam/droperidol anesthesia and experienced transient worsening of her preoperative upper and lower extremity weakness postoperatively.4 The authors hypothesized a “neurochemical effect” of anesthesia on supraspinal neuronal circuits in the context of an altered blood–spinal cord barrier and/or severely compromised spinal cord function.4 More recently, Joffe et al. described the case of a 52-year-old woman who developed transient exacerbation of preoperative left-sided weakness after elective anterior cervical discectomy and fusion performed under midazolam, fentanyl, and propofol anesthesia.5 Alternative explanations for the observed postoperative neurological worsening were considered, but neurapraxia from the surgery itself was felt unlikely. 1) The sciatic nerve itself was identified without being manipulated and was a safe distance from our more superficial biopsy; nerve stimulation produced good contractions after the biopsy. 2) The immediate nature of the paralysis of the entire sciatic nerve would also be unusual for a postoperative hematoma, which typically would present with an evolving deficit. The rapid onset and resolution of symptoms within 1 hour, together with a reassuring postoperative wound examination, made this unlikely. We also note that a sciatic nerve infiltrated with lymphoma may increase its susceptibility to “double crush” injuries during the procedure (i.e., increased chance of injury with minor retraction or manipulation distal to the tumor); however, strong contractions following the biopsy argue against this. For completeness, 1) the patient was prone for the procedure, so positioning palsy was not a consideration; and 2) local anesthesia was not used during the procedure. Lessons While it remains a diagnosis of exclusion, differential awakening after peripheral nerve surgery should be considered when patients experience neurological worsening immediately after emergence from anesthesia, particularly in the setting of infiltrative disease. In such cases, a brief period of close observation with serial neurological examinations may be appropriate while concurrently evaluating for causes that require urgent intervention. Although current understanding of differential awakening remains limited to small case series and anecdotal reports, the phenomenon following peripheral nerve surgery may reflect mechanisms analogous to those proposed for intracranial lesions. Further study is needed to better define risk factors, underlying pathophysiology, and optimal perioperative management. Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. Author Contributions Conception and design: Spinner, Texakalidis. Acquisition of data: Spinner, Texakalidis, Jones. Analysis and interpretation of data: Spinner, Texakalidis. Drafting the article: Spinner, Chow. Critically revising the article: all authors. Reviewed submitted version of manuscript: Chow, Texakalidis. Approved the final version of the manuscript on behalf of all authors: Spinner. Administrative/technical/material support: Spinner. Study supervision: Spinner. Correspondence Robert J. Spinner: Mayo Clinic, Rochester, MN. spinner.robert@mayo.edu.